Effect of the Temporal Window of Integration of Speech Sound on Mismatch Negativity.

event-related potential mismatch negativity omission paradigm speech sound temporal window of integration

Journal

Clinical EEG and neuroscience
ISSN: 2169-5202
Titre abrégé: Clin EEG Neurosci
Pays: United States
ID NLM: 101213033

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 6 11 2023
pubmed: 13 4 2022
entrez: 12 4 2022
Statut: ppublish

Résumé

Speech-sound stimuli have a complex structure, and it is unclear how the brain processes them. An event-related potential (ERP), known as mismatch negativity (MMN), is elicited when an individual's brain detects a rare sound. In this study, MMNs were measured in response to an omitted segment of a complex sound consisting of a Japanese vowel. The results indicated that the latency from onset in the right hemisphere was significantly shorter than that in the frontal midline and left hemispheres during left ear stimulation. Additionally, the results of latency from omission showed that the latency of stimuli omitted in the latter part of the temporal window of integration (TWI) was longer than that of stimuli omitted in the first part of the TWI. The mean peak amplitude was found to be higher in the right hemisphere than in the frontal midline and left hemispheres in response to left ear stimulation. In conclusion, the results of this study suggest that would be incorrect to believe that the stimuli have strictly the characteristics of speech-sound. However. the results of the interaction effect in the latencies from omission were insignificant. These results suggest that the detection time for deviance may not be related to the stimulus ear. However, the type of deviant stimuli on latencies was found to be significant. This is because the detection of the deviants was delayed when a deviation occurred in the latter part of the TWI, regardless of the stimulation of the ear.

Identifiants

pubmed: 35410509
doi: 10.1177/15500594221093607
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

620-627

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Hiroshi Hoshino (H)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Tetsuya Shiga (T)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Yuhei Mori (Y)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Michinari Nozaki (M)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Kazuko Kanno (K)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Yusuke Osakabe (Y)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Haruka Ochiai (H)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Tomohiro Wada (T)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Masayuki Hikita (M)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Shuntaro Itagaki (S)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Itaru Miura (I)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Hirooki Yabe (H)

Department of Neuropsychiatry, Fukushima Medical University, Hikarigaoka, Fukushima-city, Fukushima, 960-1295, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH